Vivos (RDGL) Non-Current Debt (2010 - 2019)

Vivos (RDGL) posted Non-Current Debt of $3.1 million for Q1 2019, little changed sequentially from $3.1 million in Q4 2018.

Vivos (RDGL) Non-Current Debt (2010 - 2019) Analysis & Trends

Vivos has reported Non-Current Debt for 8 years, with the latest figure at $3.1 million in Q1 2019.

Quarterly Non-Current Debt changed N/A year-over-year to $3.1 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $3.1 million (changed N/A YoY) and the FY2018 annual result came in at $3.1 million, changed N/A from the prior year.
Non-Current Debt held at $3.1 million in Q1 2019 per RDGL's latest filing, from $3.1 million in the prior quarter.
Over five years, Non-Current Debt peaked at $3.1 million in Q4 2018 and troughed at $32279.0 in Q3 2018.
A 3-year average of $1.7 million and a median of $1.7 million in 2016 frame the typical range for Non-Current Debt.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn	29.60 Bn
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn	14.19 Bn
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn	26.17 Bn
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn	10.92 Bn
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn	10.09 Bn
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn	7.34 Bn
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn	1.65 Bn
10	Vivos	24.90 Mn	23.34 Mn	-3,105.00	-

Download Data